T-group (topology)

280.1.1 Ribonuclease Rh-like

Ligands and drugs

146
Member domains
40
with ligand contacts (≤ 4 Å)
27.4% of members
39
with DrugDomain annotations
26.7% of members
33
with a DrugBank compound
22.6% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 280.1.1 belongs to X-group 280 Ribonuclease Rh-like, which has 7 proteins with classified ligands. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine21
DB03685U5PUridine monophosphate6
DB019725GPGuanosine-5'-Monophosphate5
DB03403C5PCytidine-5'-Monophosphate2
DB00131AMPAdenosine phosphate1
DB02714U3P3'-Uridinemonophosphate1
DB03419URAUracil1

Most frequently bound compounds

PDB ligandNameDomains in contact
NAG2-acetamido-2-deoxy-beta-D-glucopyranose20
5GPGUANOSINE-5'-MONOPHOSPHATE5
U5PURIDINE-5'-MONOPHOSPHATE5
CAmetalCALCIUM ION4
U2PPHOSPHORIC ACID MONO-[2-(2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-4-HYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3-YL]ESTER4
C5PCYTIDINE-5'-MONOPHOSPHATE2
JKM1-[(2S,3aS,4S,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidine-2,4(1H,3H)-dione2
MNmetalMANGANESE (II) ION2
AMPADENOSINE MONOPHOSPHATE1
CSQO-[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] O-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl} hydrogen (R)-phosphorothioate1
CSVO-[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] O-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl} hydrogen (S)-phosphorothioate1
D3Z1-(5-deoxy-beta-L-xylofuranosyl)pyrimidine-2,4(1H,3H)-dione1
GPGGUANYLYL-2',5'-PHOSPHOGUANOSINE1
U3P3'-URIDINEMONOPHOSPHATE1
URAURACIL1
ZNmetalZINC ION1